Patients with cherubism typically present with noticeable swelling in the lower part of the face, particularly the jaw and cheeks. This swelling is due to the abnormal growth of fibrous tissue in place of normal bone. The condition often becomes apparent between the ages of 2 and 7. As the child grows, the facial swelling may become more pronounced, potentially leading to dental problems, such as misalignment of teeth or delayed eruption. In some cases, the eyes may appear upturned due to the swelling of the cheeks.

Diagnosing cherubism involves a combination of clinical evaluation, family history, and imaging studies. A detailed physical examination is crucial, focusing on the facial structure and dental alignment. X-rays or CT scans of the jaw can reveal characteristic bone changes, such as cyst-like areas in the jawbones. Genetic testing may be conducted to confirm mutations in the SH3BP2 gene, which is associated with cherubism.

There is no specific cure for cherubism, and treatment is generally focused on managing symptoms and complications. In mild cases, regular monitoring may be sufficient. For more severe cases, surgical intervention might be necessary to correct facial deformities or dental issues. Orthodontic treatment can help address dental misalignment. Psychological support may also be beneficial for children dealing with self-esteem issues due to their appearance.

The prognosis for individuals with cherubism is generally favorable. The condition often stabilizes after puberty, and in many cases, the facial swelling decreases significantly as the individual reaches adulthood. However, some residual facial deformity may persist. Regular follow-up is important to monitor any changes and address dental or orthodontic needs.

Cherubism is caused by mutations in the SH3BP2 gene, which plays a role in bone remodeling and immune system function. This genetic mutation is inherited in an autosomal dominant pattern, meaning a single copy of the altered gene in each cell is sufficient to cause the disorder. However, the severity of the condition can vary even among family members.

Cherubism is a rare condition, with its exact prevalence unknown. It affects both males and females, although some studies suggest it may be slightly more common in males. The condition is often identified in early childhood, but due to its rarity, it may be underdiagnosed or misdiagnosed.

In cherubism, the SH3BP2 gene mutation leads to abnormal signaling pathways that affect bone remodeling. This results in the replacement of normal bone tissue with fibrous tissue, particularly in the jawbones. The fibrous tissue causes the characteristic swelling and can interfere with normal bone development and dental eruption.

Currently, there are no known preventive measures for cherubism, as it is a genetic condition. Genetic counseling may be beneficial for families with a history of cherubism to understand the risks and implications of passing the condition to future generations.

Cherubism is a rare genetic disorder characterized by symmetrical swelling of the cheeks and jaw due to abnormal bone growth. It is caused by mutations in the SH3BP2 gene and is inherited in an autosomal dominant pattern. While there is no cure, treatment focuses on managing symptoms and complications. The condition often stabilizes after puberty, with many individuals experiencing a reduction in facial swelling.

For patients and families dealing with cherubism, understanding the condition is crucial. It is important to know that while the facial changes can be distressing, the condition often improves with age. Regular dental check-ups and monitoring by healthcare professionals can help manage any complications. Support groups and counseling can provide emotional support and help individuals cope with the social and psychological aspects of the condition.